ErbB receptors in fetal endothelium-A potential linkage point for inflammation-associated neonatal disorders

Cytokine

Volumn 36, Issue 5-6, 2006, Pages 267-275

  Bueter, Wolfgang ^a   Dammann, Olaf ^a,b,c   Zscheppang, Katja ^a   Korenbaum, Elena ^a   Dammann, Christiane E L ^a,c  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

ErbB receptors; Newborns; Umbilical endothelial cells

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; EPIDERMAL GROWTH FACTOR RECEPTOR 3; EPIDERMAL GROWTH FACTOR RECEPTOR 4; GROWTH FACTOR; LIPOPOLYSACCHARIDE;

ARTICLE; CELL ISOLATION; CELL NUCLEUS; CELL TYPE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM; ENDOTHELIUM CELL; FETUS CELL; GESTATIONAL AGE; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; INFLAMMATION; NEWBORN; NEWBORN DISEASE; NUCLEOLUS; PATHOGENESIS; PREGNANCY; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UMBILICAL CORD BLOOD; UMBILICAL VEIN; WESTERN BLOTTING;

CELL NUCLEOLUS; CELL NUCLEUS; CELLS, CULTURED; CYTOPLASM; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FETUS; HUMANS; INFANT, NEWBORN; INFLAMMATION; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; PROTEIN TRANSPORT; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, EPIDERMAL GROWTH FACTOR; UMBILICAL CORD;

EID: 34047120181     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2007.02.002     Document Type: Article

References (43)

1. Gassmann M., Casagranda F., Orioli D., Simon H., Lai C., Klein R., et al. Aberrant neural and cardiac development in mice lacking the ErbB4 neuregulin receptor. Nature 378 6555 (1995) 390-394
2. Lee K.F., Simon H., Chen H., Bates B., Hung M.C., and Hauser C. Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature 378 (1995) 394-398
3. Sibilia M., and Wagner E.F. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 269 (1995) 234-238
4. Threadgill D.W., Dlugosz A.A., Hansen L.A., Tennenbaum T., Lichti U., Yee D., et al. Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. Science 269 (1995) 230-234
5. Dammann C.E., Nielsen H.C., and Carraway III K.L. Role of neuregulin-1 beta in the developing lung. Am J Respir Crit Care Med 167 12 (2003) 1711-1716
6. Strandjord T.P., Clark J.G., Guralnick D.E., and Madtes D.K. Immunolocalization of transforming growth factor-alpha, epidermal growth factor (EGF), and EGF-receptor in normal and injured developing human lung. Pediatr Res 38 6 (1995) 851-856
7. Currie A.E., Vyas J.R., MacDonald J., Field D., and Kotecha S. Epidermal growth factor in the lungs of infants developing chronic lung disease. Eur Respir J 18 5 (2001) 796-800
8. Le Cras T.D., Hardie W.D., Deutsch G.H., Albertine K.H., Ikegami M., Whitsett J.A., et al. Transient induction of TGF-{alpha} disrupts lung morphogenesis, causing pulmonary disease in adulthood. Am J Physiol Lung Cell Mol Physiol 287 4 (2004) L718-L729
9. Miettinen P.J., Berger J.E., Meneses J., Phung Y., Pedersen R.A., Werb Z., et al. Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor. Nature 376 (1995) 337-341
10. Dvorak B., Halpern M.D., Holubec H., Williams C.S., McWilliam D.L., Dominguez J.A., et al. Epidermal growth factor reduces the development of necrotizing enterocolitis in a neonatal rat model. Am J Physiol Gastrointest Liver Physiol 282 1 (2002) G156-G164
11. Kaukola T., Satyaraj E., Patel D.D., Tchernev V.T., Grimwade B.G., Kingsmore S.F., et al. Cerebral palsy is characterized by protein mediators in cord serum. Ann Neurol 55 2 (2004) 186-194
12. Dammann O., and Leviton A. Inflammation, brain damage and visual dysfunction in preterm infants. Semin Fetal Neonatal Med 11 5 (2006) 363-368
13. Martin C.R., and Walker W.A. Intestinal immune defences and the inflammatory response in necrotising enterocolitis. Semin Fetal Neonatal Med 11 5 (2006) 369-377
14. Speer C.P. Inflammation and bronchopulmonary dysplasia: a continuing story. Semin Fetal Neonatal Med 11 5 (2006) 354-362
15. Wang X., Rousset C.I., Hagberg H., and Mallard C. Lipopolysaccharide-induced inflammation and perinatal brain injury. Semin Fetal Neonatal Med 11 5 (2006) 343-353
16. Komuro A., Nagai M., Navin N.E., and Sudol M. WW domain-containing protein YAP associates with ErbB-4 and acts as a co-transcriptional activator for the carboxyl-terminal fragment of ErbB-4 that translocates to the nucleus. J Biol Chem 278 35 (2003) 33334-33341
17. Raabe T.D., Deadwyler G., Varga J.W., and Devries G.H. Localization of neuregulin isoforms and erbB receptors in myelinating glial cells. Glia 45 2 (2004) 197-207
18. Williams C.C., Allison J.G., Vidal G.A., Burow M.E., Beckman B.S., Marrero L., et al. The ERBB4/HER4 receptor tyrosine kinase regulates gene expression by functioning as a STAT5A nuclear chaperone. J Cell Biol 167 3 (2004) 469-478
19. Sardi S.P., Murtie J., Koirala S., Patten B.A., and Corfas G. Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain. Cell 127 1 (2006) 185-197
20. Chaudhury A.R., Gerecke K.M., Wyss J.M., Morgan D.G., Gordon M.N., and Carroll S.L. Neuregulin-1 and erbB4 immunoreactivity is associated with neuritic plaques in Alzheimer disease brain and in a transgenic model of Alzheimer disease. J Neuropathol Exp Neurol 62 1 (2003) 42-54
21. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 12 7 (2006) 824-828
22. Earp III H.S., Calvo B.F., and Sartor C.I. The EGF receptor family-multiple roles in proliferation, differentiation, and neoplasia with an emphasis on HER4. Trans Am Clin Climatol Assoc 114 (2003) 315-333 discussion 33-34
23. Carraway III K.L., Weber J.L., Unger M.J., Ledesma J., Yu N., Gassmann M., and Lai C. Neuregulin-2, a new ligand of ErbB3/ErbB4-receptor tyrosine kinases. Nature 387 6632 (1997) 512-516
24. Crovello C.S., Lai C., Cantley L.C., and Carraway III K.L. Differential signaling by the epidermal growth factor-like growth factors neuregulin-1 and neuregulin-2. J Biol Chem 273 41 (1998) 26954-26961
25. Padmakumar V.C., Abraham S., Braune S., Noegel A.A., Tunggal B., Karakesisoglou I., and Korenbaum E. Enaptin, a giant actin-binding protein, is an element of the nuclear membrane and the actin cytoskeleton. Exp Cell Res 295 2 (2004) 330-339
26. Russell K.S., Stern D.F., Polverini P.J., and Bender J.R. Neuregulin activation of ErbB receptors in vascular endothelium leads to angiogenesis. Am J Physiol 277 6 Pt 2 (1999) H2205-H2211
27. Gospodarowicz D., Brown K.D., Birdwell C.R., and Zetter B.R. Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin. J Cell Biol 77 3 (1978) 774-788
28. Kim H.S., Shin H.S., Kwak H.J., Cho C.H., Lee C.O., and Koh G.Y. Betacellulin induces angiogenesis through activation of mitogen-activated protein kinase and phosphatidylinositol 3′-kinase in endothelial cell. FASEB J 17 2 (2003) 318-320
29. Haug C., Schmid-Kotsas A., Linder T., Bachem M.G., Gruenert A., and Rozdzinski E. Influence of hepatocyte growth factor, epidermal growth factor, and mycophenolic acid on endothelin-1 synthesis in human endothelial cells. Nephrol Dial Transplant 16 12 (2001) 2310-2316
30. Dammann O., Allred E.N., Leviton A., Shen-Schwarz S., Heller D., Genest D.R., et al. Fetal vasculitis in preterm newborns: interrelationships, modifiers, and antecedents. Placenta 25 (2004) 788-796
31. Lin S.Y., Makino K., Xia W., Matin A., Wen Y., Kwong K.Y., et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 3 9 (2001) 802-808
32. Bild A.H., Turkson J., and Jove R. Cytoplasmic transport of Stat3 by receptor-mediated endocytosis. EMBO J 21 13 (2002) 3255-3263
33. Lemmon M.A., and Schlessinger J. Transmembrane signaling by receptor oligomerization. Methods Mol Biol 84 (1998) 49-71
34. Yen L., Benlimame N., Nie Z.R., Xiao D., Wang T., Al Moustafa A.E., et al. Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers. Mol Biol Cell 13 11 (2002) 4029-4044
35. Caplan M.S., and Jilling T. New concepts in necrotizing enterocolitis. Curr Opin Pediatr 13 (2001) 111-115
36. Subauste M.C., and Proud D. Effects of tumor necrosis factor-alpha, epidermal growth factor and transforming growth factor-alpha on interleukin-8 production by, and human rhinovirus replication in, bronchial epithelial cells. Int Immunopharmacol 1 7 (2001) 1229-1234
37. Hamilton L.M., Torres-Lozano C., Puddicombe S.M., Richter A., Kimber I., Dearman R.J., et al. The role of the epidermal growth factor receptor in sustaining neutrophil inflammation in severe asthma. Clin Exp Allergy 33 2 (2003) 233-240
38. Qiu Y., Ravi L., and Kung H.J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature 393 6680 (1998) 83-85
39. Grant S.L., Hammacher A., Douglas A.M., Goss G.A., Mansfield R.K., Heath J.K., et al. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells. Oncogene 21 3 (2002) 460-474
40. Husain A.N., Siddiqui N.H., and Stocker J.T. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum Pathol 29 7 (1998) 710-717
41. Smith L.E. Pathogenesis of retinopathy of prematurity. Growth Horm IGF Res 14 Suppl. A (2004) S140-S144
42. Finkenzeller G., Weindel K., Zimmermann W., Westin G., and Marme D. Activated Neu/ErbB-2 induces expression of the vascular endothelial growth factor gene by functional activation of the transcription factor Sp 1. Angiogenesis 7 1 (2004) 59-68
43. Dammann O., and Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr Opin Pediatr 12 2 (2000) 99-104